Cryosite Limited (ASX:CTE)
1.300
0.00 (0.00%)
Jul 15, 2026, 11:19 AM AEST
Cryosite Market Cap
Cryosite has a market cap or net worth of 63.45 million as of July 17, 2026. Its market cap has increased by 83.10% in one year.
Market Cap
63.45M
Enterprise Value
69.73M
Revenue
15.75M
Ranking
n/a
PE Ratio
30.28
Stock Price
1.30
ChartMarket Cap Chart
Since May 9, 2002, Cryosite's market cap has increased from 18.00 to 63.45M, an increase of 352,513,411.11%. That is a compound annual growth rate of 86.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 63.45M | 30.00% |
| Dec 29, 2025 | 48.81M | 17.65% |
| Dec 27, 2024 | 41.49M | 40.50% |
| Dec 29, 2023 | 29.53M | -17.12% |
| Dec 30, 2022 | 35.63M | 56.99% |
| Dec 31, 2021 | 22.70M | 22.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 437.83M |
| Healius | 272.31M |
| Monash IVF Group | 268.85M |
| Rhythm Biosciences | 30.79M |
| INOVIQ | 29.56M |
| BCAL Diagnostics | 28.02M |
| Microba Life Sciences | 25.58M |
| ImExHS | 16.76M |